Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Glaukos Corp (GKOS) USD0.001

Sell:$85.00 Buy:$85.02 Change: $0.88 (1.02%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
Sell:$85.00
Buy:$85.02
Change: $0.88 (1.02%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
Sell:$85.00
Buy:$85.02
Change: $0.88 (1.02%)
Market closed |  Prices as at close on 16 April 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm's canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream. It is developing three additional pipeline products: the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is a drug delivery system that is designed to be implanted in the eye to continuously deliver therapeutic levels of medication for extended periods of time to lower intraocular pressure in glaucoma patients.

Contact details

Address:
229 Avenida Fabricante
SAN CLEMENTE
92672-7531
United States
Telephone:
+1 (949) 3679600
Website:
https://www.glaukos.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
GKOS
ISIN:
US3773221029
Market cap:
$3.87 billion
Shares in issue:
45.79 million
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • William Link
    Independent Chairman of the Board
  • Thomas Burns
    President, Chief Executive Officer, Director
  • Joseph Gilliam
    Chief Financial Officer, Senior Vice President - Corporate Development
  • Chris Calcaterra
    Chief Operating Officer
  • L. Jay Katz
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.